Longeveron Inc - Class A — Balance Sheet (NASDAQ:LGVN) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics

Quarterly Annual

Total assets 42.77 M27.41 M12.08 M25.56 M Total liabilities 5.31 M6.91 M5.34 M3.67 M Total equity 37.45 M20.5 M6.74 M21.89 M Total liabilities & shareholders' equities 42.77 M27.41 M12.08 M25.56 M Total debt 02.31 M—— Net debt -9.96 M-17.34 M——

Notizie

Longeveron chiude un finanziamento da 15 milioni di dollari, estende la liquidità fino al 4° trimestre 2026

Longeveron closes $15 million financing, extends runway to 4Q26

Longeveron ottiene finanziamento da 15 milioni di dollari, punta ad altri 15 milioni con risultati degli studi

Longeveron secures $15M financing, eyes $15M more on trial results

Longeveron pubblica i risultati dello studio di fase 2b sulle cellule staminali

Longeveron publishes phase 2b stem cell trial results in journal

Longeveron nomina Stephen Willard nuovo CEO in vista dei risultati di trial cruciali

Longeveron appoints Stephen Willard as new CEO ahead of pivotal trial results

Longeveron receives Japanese patent for stem cell potency assay methods

Longeveron prepares for pivotal HLHS therapy data with FDA meeting

Longeveron receives patent for stem cell therapy targeting female sexual dysfunction

I dirigenti di Longeveron parleranno al Forum CVCT sui trial di terapia cellulare